Orchestra BioMed Holdings, Inc. logo OBIO - Orchestra BioMed Holdings, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 5
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $11.50 DETAILS
HIGH: $13.00
LOW: $10.00
MEDIAN: $11.50
CONSENSUS: $11.50
UPSIDE: 103.18%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2
Revenue
Revenue 0.1 0.1 30.9 0.9 0.8 0.9 0.3 1.0 0.8 0.6 0.3 0.4 0.9 1.2 1.1 1.2 0.4 0.9 (2.5) 1.3 (1.0) 1.3 0 0 0
Cost of Revenue 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0 0 0
Gross Profit 0.1 0.0 30.9 0.8 0.8 0.8 0.2 0.9 0.7 0.5 0.2 0.4 0.9 1.1 1.1 1.1 0.3 0.8 (2.5) 1.3 (1.0) 1.3 0 0 0
Operating Expenses
R&D Expenses 16.6 15.8 16.8 14.0 13.9 13.5 11.0 11.6 11.1 9.1 8.5 8.6 8.5 8.3 7.5 5.9 5.0 3.5 3.5 3.7 2.6 3.1 0 0 0
SG&A Expenses 5.8 6.3 7.3 7.1 6.3 6.3 5.9 5.7 6.5 5.8 4.1 6.3 5.3 4.4 3.3 5.3 2.9 2.5 1.9 2.0 1.9 2.1 0.1 0.1 0.0
Other Expenses 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 22.4 22.1 24.1 21.1 20.1 19.7 16.9 17.3 17.6 14.9 12.7 14.9 13.8 12.7 10.9 11.2 8.0 6.0 5.4 5.7 4.5 5.2 0.1 0.1 0.0
Operating Income
Operating Income (22.4) (22.1) 6.8 (20.3) (19.3) (18.9) (16.7) (16.3) (16.9) (14.4) (12.5) (14.5) (13.0) (11.5) (9.8) (10.1) (7.6) (5.1) (7.9) (4.4) (5.6) (3.9) (0.1) (0.1) (0.0)
Interest Expense 0 0.8 0.8 0.5 0 0 0 0 0 0 0 0 0 0.4 0 0 0.2 0.2 0 0 0 0 0 0 0
Interest Income 0 0 0 0 0 0.2 0.5 0.9 0.9 1.0 1.1 0.9 0.9 1.2 0.5 0.1 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (23.7) (19.8) 7.1 (20.7) (19.3) (18.7) (16.1) (15.3) (15.9) (13.4) (12.7) (13.2) (12.0) (10.5) (9.7) (10.2) (7.6) (5.4) (8.0) (5.2) (6.1) (3.9) (0.1) (0.1) (0.0)
EBIT (23.8) (19.9) 7.0 (20.8) (19.4) (18.8) (16.2) (15.4) (16.0) (13.5) (12.8) (13.3) (12.0) (10.6) (9.8) (10.3) (7.6) (5.5) (8.1) (5.3) (6.2) (3.9) (0.1) (0.1) (0.0)
Income Before Tax (23.8) (20.7) 6.2 (20.8) (19.4) (18.8) (16.2) (15.4) (16.0) (13.5) (12.8) (13.3) (12.0) (10.9) (9.8) (10.3) (7.8) (5.7) (8.1) (5.3) (6.2) (3.5) (0.1) (0.1) (0.0)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (23.8) (20.7) 6.2 (20.8) (19.4) (18.8) (16.2) (15.4) (16.0) (13.5) (12.8) (13.3) (12.0) (10.9) (9.8) (10.3) (7.8) (5.7) (8.1) (5.3) (6.2) (3.5) (0.1) (0.1) (0.0)
Per Share Data
EPS (Basic) -0.38 -0.33 0.12 -0.40 -0.50 -0.49 -0.42 -0.41 -0.45 -0.38 -0.36 -0.38 -0.35 -0.40 -0.42 -0.44 -0.25 -0.01 -0.39 -0.26 -0.30 -0.17 -0.00 -0.00
EPS (Diluted) -0.38 -0.33 0.12 -0.40 -0.50 -0.49 -0.42 -0.41 -0.45 -0.38 -0.36 -0.38 -0.35 -0.40 -0.42 -0.44 -0.25 -0.01 -0.39 -0.26 -0.30 -0.17 -0.00 -0.00
Shares Outstanding 63.8 62.7 50.0 52.2 38.4 38.2 38.1 37.6 35.8 35.8 35.8 35.2 34.6 27.6 23.3 23.3 31.6 31.6 20.4 20.4 20.4 20.4 20.4 20.4 20.4
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2
Current Assets
Cash & Cash Equivalents 20.5 28.4 34.7 42.0 18.7 18.3 22.3 25.6 23.7 23.3 30.6 19.1 16.4 18.7 19.8 97.0 107.0 29.3 9.9 1.8 1.9 2.0 2.0 2.0 0.2
Short-Term Investments 89.5 66.0 71.8 53.8 15.2 31.5 44.6 41.3 41.5 51.7 57.0 89.8 101.4 108.5 64.0 0.3 0.6 0.7 1.0 0 0 0 0 0 0
Net Receivables 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0 0 0 0 0 0
Inventory 0.2 0.3 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.1 0.0 0.1 0 0 0 0 0 0
Other Current Assets 0 1.4 1.0 1.5 1.7 1.8 2.1 1.3 1.1 1.2 1.3 1.1 1.5 2.3 0.5 0 0 0 0 0 0 0 0 0 0
Total Current Assets 111.2 96.2 107.9 97.8 35.9 51.9 69.2 68.6 66.5 76.4 89.1 110.2 119.6 129.9 84.7 98.5 108.6 30.4 11.3 1.9 2.0 2.1 2.1 2.2 0.2
Non-Current Assets
Property, Plant & Equipment 3.2 3.2 3.2 3.2 3.2 3.4 3.5 3.0 2.6 2.8 2.8 3.1 3.3 3.5 3.7 3.8 3.8 3.6 1.1 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 0.4 0.4 160.0 160.0 160.0 160.0 160.0 0
Other Non-Current Assets 1.2 1.3 1.2 1.3 1.3 1.3 1.0 1.3 0.8 0.9 0.8 0.6 0.5 0.4 4.7 3.5 2.2 1.0 0.7 0 0 0 0 0 0.2
Total Non-Current Assets 4.5 4.4 6.9 7.0 6.9 7.1 7.0 6.8 5.9 6.2 6.1 6.2 6.3 6.4 10.9 9.8 8.5 4.9 2.2 160.0 160.0 160.0 160.0 160.0 0.2
Total Assets 115.7 100.7 114.9 104.8 42.8 59.1 76.2 75.3 72.4 82.6 95.2 116.4 125.9 136.3 95.6 108.3 117.1 35.4 13.5 161.9 162.0 162.1 162.2 162.2 0.3
Current Liabilities
Account Payables 6.1 6.3 6.1 8.5 5.3 5.6 5.1 4.7 6.3 3.4 2.9 3.1 3.0 2.8 4.0 7.7 3.8 2.2 2.0 0 0 0 0 0 0
Short-Term Debt 0 0.8 0.8 0 0 0 0 0 0 0 0 9.6 0 0 0 0 0 1 2 0 0 0 0 0 0.3
Deferred Revenue 0 0 0 4.6 4.5 3.9 4.4 4.1 3.7 3.1 2.5 3.7 4.3 5.3 6.4 0 5.0 0 5.5 0 0 0 0 0 0
Other Current Liabilities 0 5.4 5.7 1.8 2.0 1.0 2.6 2.6 2.5 1.0 2.7 1.7 1.9 2.3 4.6 7.0 9.0 6.6 2.0 0.1 0.2 0.2 0.1 0.1 0.0
Total Current Liabilities 13.5 13.7 16.7 20.7 17.1 15.5 16.2 16.2 14.5 10.4 11.2 21.5 11.9 12.1 18.6 20.1 19.7 13.0 12.2 0.1 0.2 0.2 0.1 0.1 0.3
Non-Current Liabilities
Long-Term Debt 20.4 32.1 30.8 14.2 14.4 14.3 14.3 0 0 0 0 0 9.6 9.5 9.5 9.5 9.4 3.7 3.7 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 (14.9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 51.8 3.2 3.1 16.4 0.2 0.1 0.0 0 0 0 14.9 0.3 0.2 0.2 0.2 15.5 165.9 16.5 52.0 5.6 5.6 5.6 5.6 5.6 0
Total Non-Current Liabilities 72.8 36.0 34.7 40.4 25.5 26.7 27.0 12.9 13.8 15.0 16.0 15.2 24.6 24.5 24.5 26.8 193.9 22.3 72.5 5.6 5.6 5.6 5.6 5.6 0
Total Liabilities 86.3 49.7 51.5 61.1 42.5 42.2 43.2 29.1 28.3 25.4 27.2 36.7 36.4 36.5 43.0 46.9 213.6 35.3 84.8 5.7 5.8 5.8 5.7 5.7 0.3
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 160.0 160.0 151.2 151.3 160.0 151.5 0.0
Retained Earnings (407.0) (383.3) (362.6) (368.8) (348.0) (328.6) (309.9) (293.7) (278.3) (262.3) (248.9) (236.0) (222.7) (210.7) (199.7) (190.0) (179.7) (171.9) (166.1) (3.9) (0.4) (0.3) (3.6) (0.1) (0.0)
Accumulated Other Comprehensive Income (0.1) (0.0) 0.1 0.0 0.0 0.0 0.1 0.1 (0.0) (0.0) (0.0) (0.1) (0.1) (0.0) (0.0) 0 0 0 (211.5) 0 0 0 0 0 0
Total Stockholders' Equity 29.4 51.0 63.4 43.7 0.3 16.9 33.0 46.2 44.1 57.2 68.0 79.7 89.4 99.8 52.5 61.4 (96.4) 0.1 (71.2) 156.1 156.2 156.3 156.4 156.5 0.0
Total Liabilities & Equity 115.7 100.7 114.9 104.8 42.8 59.1 76.2 75.3 72.4 82.6 95.2 116.4 125.9 136.3 95.6 108.3 117.1 35.4 13.5 161.9 162.0 162.1 162.2 162.2 0.3
Debt Metrics
Total Debt 21.8 33.6 32.4 16.0 16.4 16.4 16.5 1.8 1.5 1.6 1.7 11.5 11.6 11.7 11.9 12.0 12.1 7.4 5.7 0 0 0 0 0 0.3
Net Debt 1.3 5.3 (2.3) (26.0) (2.4) (1.9) (5.7) (23.8) (22.3) (21.7) (28.9) (7.6) (4.8) (7.0) (7.9) (85.0) (94.8) (21.9) (4.3) (1.8) (1.9) (2.0) (2.0) (2.0) 0.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q3
Operating Activities
Net Income (23.8) (20.7) 6.2 (20.8) (19.4) (18.8) (16.2) (15.4) (16.0) (13.5) (12.8) (13.3) (12.0) (10.9) (9.8) (10.3) (7.8) (5.7) (8.1) (5.3) (6.2) (3.5) (0.1)
Depreciation & Amortization 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0
Stock-Based Compensation 2.5 2.9 2.8 3.0 3.2 3.0 2.9 2.4 2.8 2.6 0.9 3.5 1.7 1.5 0.9 2.2 0.3 0.1 0.0 0.1 0.1 0.1 0
Change in Working Capital 0.1 (3.7) (12.3) 2.5 0.4 (1.0) (1.4) (1.2) 3.1 (1.8) (0.1) 0.6 0.6 (4.4) 0.1 0.3 (0.6) (0.3) 0.1 (0.1) (0.1) 0.2 (0.2)
Other Non-Cash Items 1.7 (0.8) 0.9 0.6 0.1 0.1 1.0 0.5 (0.1) (0.5) 2.1 (1.2) (0.8) (0.6) (0.0) 0.5 0.0 0.2 3.2 0.3 1.6 (2.3) (0.0)
Operating Cash Flow (19.3) (22.2) (2.3) (14.6) (15.5) (16.6) (13.5) (13.7) (10.2) (13.1) (11.0) (10.3) (10.5) (14.4) (8.7) (7.3) (9.1) (5.3) (4.6) (4.8) (4.4) (5.6) (0.2)
Investing Activities
Capital Expenditure (0.3) (0.2) (0.0) (0.3) (0.0) (0.1) (0.1) (0.1) (0.1) (0.0) 0.0 (0.0) (0.0) (0.0) (0.1) (0.2) (0.3) (0.0) (0.1) (0.1) 0.0 (0.1) 0
Acquisitions 0 0 0 0 0 0 (0.6) 0 0 0 (33.1) 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (43) (13.1) (25.6) (47.8) 0 (2.9) (20.3) (10.0) (18.7) (23.7) (4.0) (38.5) (56.1) (43.5) (63.3) 0 (0.2) 0 0 0 0 0 (160)
Sales/Maturities of Investments 19.9 23.6 8.0 9.5 16.4 16.0 17.2 10.6 29.2 29.6 37.1 51.5 64.2 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0.0 0 0 0 0 0 0 0 0 0 33.1 0 0 0 0 0 0 0 (0.2) 6.3 6.3 0.8 0
Investing Cash Flow (23.3) 10.3 (17.7) (38.6) 16.4 13.0 (3.8) 0.6 10.4 5.9 33.2 12.9 8.1 (43.5) (63.4) (0.2) (0.5) (0.0) (0.3) 6.3 6.3 0.7 (160)
Financing Activities
Net Debt Issuance 20 0 (1.0) 18.9 0 0 15 0 0 0 (10.8) 0 0 0 0 0 4.6 (1) (1) (1) (1) (1) (0.3)
Stock Repurchased (0.6) 0 0 0 (0.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 15.4 (0.4) (0.5) (0.3) 0 (0.4) (1.1) 0 0 0 0 0 0.1 56.8 (5.1) (2.5) 82.6 (1.5) 0.0 0 0 0 0
Financing Cash Flow 34.7 5.5 12.7 76.4 (0.4) (0.3) 13.9 15.0 0.2 0.0 (10.7) 0.0 0.1 56.8 (5.1) (2.5) 87.2 24.8 (1.0) (1) (1) (1) 162.1
Cash Position
Net Change in Cash (7.9) (6.3) (7.3) 23.3 0.4 (3.9) (3.3) 1.9 0.4 (7.2) 11.5 2.7 (2.3) (1.1) 19.0 (10.0) (0.1) 19.4 (5.9) 0.4 0.9 (5.8) 1.8
Cash at Beginning 28.4 34.7 42.0 18.7 18.3 22.3 25.6 23.7 23.3 30.6 19.1 16.4 18.7 19.8 0.7 107.0 1.4 9.9 15.9 15.4 14.5 20.3 0.2
Cash at End 20.5 28.4 34.7 42.0 18.7 18.3 22.3 25.6 23.7 23.3 30.6 19.1 16.4 18.7 19.8 97.0 1.3 29.3 9.9 15.9 15.4 14.5 2.0
Free Cash Flow (19.6) (22.4) (2.3) (14.9) (15.6) (16.7) (13.6) (13.8) (10.3) (13.1) (11.0) (10.3) (10.5) (14.4) (8.8) (7.5) (9.4) (5.4) (4.7) (4.9) (4.4) (5.7) (0.2)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2
Income Statement
Revenue 0.1 0.1 30.9 0.9 0.8 0.9 0.3 1.0 0.8 0.6 0.3 0.4 0.9 1.2 1.1 1.2 0.4 0.9 (2.5) 1.3 (1.0) 1.3 0 0 0
Gross Profit 0.1 0.0 30.9 0.8 0.8 0.8 0.2 0.9 0.7 0.5 0.2 0.4 0.9 1.1 1.1 1.1 0.3 0.8 (2.5) 1.3 (1.0) 1.3 0 0 0
Operating Income (22.4) (22.1) 6.8 (20.3) (19.3) (18.9) (16.7) (16.3) (16.9) (14.4) (12.5) (14.5) (13.0) (11.5) (9.8) (10.1) (7.6) (5.1) (7.9) (4.4) (5.6) (3.9) (0.1) (0.1) (0.0)
Net Income (23.8) (20.7) 6.2 (20.8) (19.4) (18.8) (16.2) (15.4) (16.0) (13.5) (12.8) (13.3) (12.0) (10.9) (9.8) (10.3) (7.8) (5.7) (8.1) (5.3) (6.2) (3.5) (0.1) (0.1) (0.0)
EPS (Diluted) -0.38 -0.33 0.12 -0.40 -0.50 -0.49 -0.42 -0.41 -0.45 -0.38 -0.36 -0.38 -0.35 -0.40 -0.42 -0.44 -0.25 -0.01 -0.39 -0.26 -0.30 -0.17 -0.00 -0.00
Balance Sheet
Cash & Equivalents 20.5 28.4 34.7 42.0 18.7 18.3 22.3 25.6 23.7 23.3 30.6 19.1 16.4 18.7 19.8 97.0 107.0 29.3 9.9 1.8 1.9 2.0 2.0 2.0 0.2
Total Assets 115.7 100.7 114.9 104.8 42.8 59.1 76.2 75.3 72.4 82.6 95.2 116.4 125.9 136.3 95.6 108.3 117.1 35.4 13.5 161.9 162.0 162.1 162.2 162.2 0.3
Total Debt 21.8 33.6 32.4 16.0 16.4 16.4 16.5 1.8 1.5 1.6 1.7 11.5 11.6 11.7 11.9 12.0 12.1 7.4 5.7 0 0 0 0 0 0.3
Stockholders' Equity 29.4 51.0 63.4 43.7 0.3 16.9 33.0 46.2 44.1 57.2 68.0 79.7 89.4 99.8 52.5 61.4 (96.4) 0.1 (71.2) 156.1 156.2 156.3 156.4 156.5 0.0
Cash Flow
Operating Cash Flow (19.3) (22.2) (2.3) (14.6) (15.5) (16.6) (13.5) (13.7) (10.2) (13.1) (11.0) (10.3) (10.5) (14.4) (8.7) (7.3) (9.1) (5.3) (4.6) (4.8) (4.4) (5.6) (0.2)
Capital Expenditure (0.3) (0.2) (0.0) (0.3) (0.0) (0.1) (0.1) (0.1) (0.1) (0.0) 0.0 (0.0) (0.0) (0.0) (0.1) (0.2) (0.3) (0.0) (0.1) (0.1) 0.0 (0.1) 0
Free Cash Flow (19.6) (22.4) (2.3) (14.9) (15.6) (16.7) (13.6) (13.8) (10.3) (13.1) (11.0) (10.3) (10.5) (14.4) (8.8) (7.5) (9.4) (5.4) (4.7) (4.9) (4.4) (5.7) (0.2)